CRDL News

Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in ProceedsPR NewswireTORONTO, Sept. 16, 2026 Proceeds strengthen balance sheet ahead of pivotal Phase III MAVERIC trial data readout in...

INDV, IRWD, RLMD, LRMR and CRDL could offer significant upside as biotech sentiment improves, backed by catalysts and differentiated pipelines.

Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by...

Here is how Aspen Pharmacare (APNHY) and Cardiol Therapeutics Inc. (CRDL) have performed compared to their sector so far this year.

Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference PR Newswire TORONTO, Sept. 9, 2026 TORONTO, Sept. 9, 2026...

Here is how Cardiol Therapeutics Inc. (CRDL) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.

Does Cardiol Therapeutics Inc. (CRDL) have what it takes to be a top stock pick for momentum investors? Let's find out.

Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference PR Newswire TORONTO, Aug. 5, 2026 TORONTO, Aug. 5, 2026 /PRNewswire/ -- Cardiol...

Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association PR Newswire TORONTO, July 14, 2026 Peer-reviewedJAHA...